2,4,5-Trimethyl-3-oxazoline
Common Name: |
2,4,5-Trimethyl-3-oxazoline |
IUPAC Name: |
2,4,5-trimethyl-2,5-dihydro-1,3-oxazole |
Molecular Formula: |
C11H14O3 |
SMILES: |
CC1C(=NC(O1)C)C |
Inchi: |
1S/C6H11NO/c1-4-5(2)8-6(3)7-4/h5-6H,1-3H3 |
Inchi Key: |
YFSGRMONVCFYTC-UHFFFAOYSA-N |
Cas No: |
22694-96-8 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
194.23 |
Mass (g/mol) |
113.084 |
Molar Refractivity |
53.45 |
Net Charge |
|
HBD |
|
HBA |
3 |
Rt Bonds |
6 |
Rings |
1 |
TPSA |
35.53 |
Hetero Atoms |
2 |
Heavy Atoms |
14 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
125.00 to 127.00 |
Vapor Pressure (mmHg@25.00 °C) |
8.099 |
Vapor Density (Air =1) |
3.8 |
Fraction Csp3 |
0.36 |
LogP |
1.212 |
iLOGP |
2.70 |
XLOGP3 |
2.25 |
WLOGP |
2.02 |
MLOGP |
1.96 |
ESOL Log S |
-2.38 |
ESOL Solubility (mg/ml) |
0.804 |
ESOL Solubility (mol/l) |
0.004 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-2.63 |
Ali Solubility (mg/ml) |
0.45 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-3.43 |
Silicos-IT Solubility (mg/ml) |
0.07 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.89 |
Bioavailability Score |
0.55 |
Caco2 |
0 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.543 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.689 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |